One limitation of using an ACE inhibitor to assess the contribution of AngII to hypertension in BPH/2 mice is that ACE inhibitors also reduce the degradation of bradykinin, which itself could have a vasodilatory effect. This evidence concerns the gene AGT and hypertensive disorder.